Feed TEVA
Market cap
$47.5B
Enterprise value
$60.7B
P/E
67.3x
Forward P/E
19.8x
PEG
-
P/S
2.7x
P/FCF
35.2x
EV/EBITDA
23.4x
ROIC
6.8%
Gross margin
52.5%
Net margin
4.1%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
5.1x
Beta
0.82
Free float
99.8%

About the company

Teva Pharmaceutical Industries (TEVA) is an Israeli pharmaceutical company specializing in the development, production, and distribution of generic drugs and specialty pharmaceutical products. With a broad portfolio of generic medicines and proprietary products in areas such as neurology, oncology, and respiratory diseases, Teva is one of the largest producers of generic drugs in the world. The company is known for its ability to provide affordable medications and innovative treatment options for patients worldwide. Teva also invests in the research and development of new pharmaceuticals and biologics. Teva Pharmaceutical Industries (TEVA) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on generic drugs and specialty treatments.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Richard D. Francis

Employees

32,008

Headquarters

Tel Aviv

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.